Acrivon Therapeutics
ACRV
ACRV
54 hedge funds and large institutions have $136M invested in Acrivon Therapeutics in 2024 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7.24% more ownership
Funds ownership: 68.7% → 75.95% (+7.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
54
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$20.5M | |
| 2 | +$13.6M | |
| 3 | +$3.83M | |
| 4 |
SCV
Sands Capital Ventures
Arlington,
Virginia
|
+$2.73M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.55M |
Top Sellers
| 1 | -$683K | |
| 2 | -$279K | |
| 3 | -$126K | |
| 4 |
PCM
Prelude Capital Management
New York
|
-$93K |
| 5 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
-$77.3K |